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Background: Remifentanil is useful during general anesthesia because of its rapid onset and short acting time. 
However, some studies report that due to opioid-induced hyperalgesia (OIH) and tolerance, remifentanil also 
increases early postoperative pain. The occurrence of OIH and opioid-induced tolerance is mainly thought to be due 
to central sensitization by the activation of NMDA receptors. Therefore, we investigated the effects of continuous 
infusion of ketamine, an NMDA receptor antagonist, on postoperative pain and the quantity of opioids used.
Methods: 40 patients scheduled to undergo laparoscopic gynecologic surgery were randomly allocated into two 
groups. Anesthesia was equally maintained with sevoflurane and 4 ng/ml of remifentanil in all patients. Ketamine (0.3 
mg/kg) was injected and followed with a continuous dosage of 3 μl/kg/min in the ketamine group (n = 20) while the 
control group was injected and infused with an equal amount of normal saline. We compared postoperative VAS up 
to 7 hours and morphine demand through PCA. 
Results: Postoperative VAS and morphine demand was significantly lower in the ketamine group 2 and 3 hours after 
surgery, respectively. 
Conclusions: When general anesthesia is maintained with sevoflurane and remifentanil in patients undergoing 
laparoscopic gynecologic surgery, continuous infusion of low dose ketamine decreased early postoperative pain and 
the quantity of opioids used. (Korean J Anesthesiol 2011; 61: 238-243)
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Introduction
The use of opioids aid in blocking adverse reactions derived 
from strong external stimulations during surgery, stabilizing 
vital signs and decreasing doses of inhalant or intravenous 
anesthetics. However, not only do complications such as 
bradycardia and hypotension occur, but delayed postoperative 
awakening and ventilatory suppression result due to the drugs 
long duration time, making opioid use problematic. 
Remifentanil, which is a selective μ-opioid agonist, has 
rapid onset and a short acting period and, thus is useful in 
inducing sedation during general anesthesia for surgery or 
in the emergency room. Because it is catabolized by non-
selective esterases which are widely distributed throughout the 
blood or tissue, clearance rate is high and hardly any retention 
is detected when discontinued. Elimination highlife is 3-5 
minutes, so despite continuous infusion or the total dosage 
administered, its effects are quickly lost, decreasing risks of 
delayed postoperative awakening or ventilatory suppression [1].
Recently, the question as to whether the use of opioids make 
postoperative pain control difficult due to induction opioid-
induced hyperalgesia (OIH) has been raised. Several studies 
claim that the use of remifentanil during surgery induces OIH 
and opioid-induced tolerance, increasing postoperative pain 
and the use of postoperative opioids after surgery [2-4]. Also, 
the shorter the acting period of the opioid, such as remifentanil, 
the more rapidly and frequently hyperalgesia occurs [5].
OIH and opioid-induced tolerance is known to be centrally 
sensitized through activation of NMDA receptors [6]. Central 
sensitization occurs through a sequence of modulations from 
the dorsal horn of the spines, releasing glutamate, aspartate, 
and substance P from excitatory synapse membranes. These 
substances then activate postsynaptic NMDA receptors, 
increasing intake of the secondary messenger Ca
2, inducing 
central sensitization. Ketamine is a non-competitive NMDA 
receptor antagonist which blocks central sensitization by 
inhibiting activation of excitatory amino acids such as gluta-
mate on NMDA receptors [7]. 
A single continuous infusion of 0.25-0.5 mg/kg ketamine, 
or preoperative and intraoperative continuous infusion 
of ketamine at a rate less than 20 μg/kg/min can be used 
effectively during surgery because it decreases side effects, such 
as nightmares or hallucination, when used for pain control or 
analgesia [8,9]. 
We studied the effects of a continuous infusion of low dose 
ketamine on postoperative pain and the amount of post-
operative opioids used in patients undergoing laparoscopic 
obste  tric surgery anesthetized with sevoflurane and remifen-
tanil. 
Materials and Methods
40 female patients classified as ASA 1 or 2 scheduled for 
laparoscopic gynecologic surgery under general anesthesia 
were the objects of study. Patients with a history of drug abuse, 
renal or hepatic diseases and those taking analgesics were 
excluded. After acknowledgement from the hospital’s ethics 
committee, informed consent was received after full description 
of the study and its methods. 
All patients were premedicated with 2 mg of midazolam 
and 0.2 mg of glycopyrrolate intramuscularly and 20 mg of 
famotidine intravenously 30 minutes before arriving to the 
operating room. In the operating room, basic non-invasive 
monitoring of baseline blood pressure, echocardiogram and 
saturation were measured, along with BIS after application of 
the sensor to the forehead. 
Anesthetic induction was conducted using 1.5 mg/kg of 
propofol and remifentanil with an effect site target concen-
tration of 4.0 ng/ml using an Orchestra Pump (orchestra 
infusion workstation, Fresnius Vial, France). After goal concen-
tration was attained and loss of consciousness confirmed, 0.6 
mg/kg of rocuronium was administered for muscle relaxation. 
Ninety seconds after bagging, tracheal intubation was 
performed. 
Patients were randomly allocated into two groups according 
to which treatment they were to be administered during 
surgery. The ketamine group (group K, n = 20) was injected 
with 0.3 mg/kg of ketamine during induction and continuously 
infused with 3 μg/kg/min of ketamine during surgery. The 
control group (group C, n = 20) was injected and infused with 
normal saline at the same volumes as the ketamine group. 
Anesthesia was maintained with vital signs within a 20% 
range from baseline and BIS was maintained between 40 and 
60. Remifentanil was maintained at an effect site concentration 
of 3-4 ng/ml and sevoflurane was inhaled at 1.5-2 vol%.
Ten minutes before surgery ended, PCA (Pain Management 
Provider, Abbott, USA) was initiated with a 120 ml mixture 
containing 40 mg of morphine sulfate, 120 mg of ketorolac, 
and 12 mg of ondansetron. Loading dose was set at 3 ml, with 
a continous infusion at 1.5 ml/hr and additional doses of 1.5 
ml with a lockout time of 15 minutes. In the recovery room, if 
the patient sought more pain control or if VAS was above 4, a 
trained nurse administered additional dosages from the PCA. 
After suturing of the skin, infusion of ketamine or normal 
saline was discontinued, along with sevoflurane and 
remifentanil. Ondansetron (4 mg) for antiemetic effects was 
administered. When BIS was above 80, with sufficient self 
respiration and eyes opening on command, the patient was 
extubated. The time from when the drugs were discontinued 
to when the patient was transferred to the recovery room was 240 www.ekja.org
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recorded. 
At 20 minutes intervals for 1 hour in the recovery room, at 90 
minutes, then 2, 3, 4, and 7 hours post operation, the degree of 
pain, nausea/vomiting, nightmares and hallucinations along 
with the total amount of opioids used were measured. VAS 
(visual analogue scale) was used to measure the degree of pain 
and consciousness was evaluated using the Riker sedation-
agitation scale (Table 1).
All measurements were shown as mean ± SD. Statistical 
analyses were performed with SPSS (version 15.0, SPSS Inc, 
Chicago, IL, USA). An unpaired t-test was used to compare 
endpoints for the two groups and results were considered 
statistically significant when P < 0.05.
Results
No significant differences in the demographic data were 
evident among the two groups (Table 2). Mean blood pressure 
and heart rate during surgery were not significantly different 
between the two groups. BIS was higher in the K group right 
after intubation, before incision as well as 5 and 20 minutes 
after incision (Table 3). 
Postoperative nausea and vomiting occurred in 1 patient 
in group C in the recovery room and in 1 patient in the ward. 
For group K, 1 patient experienced nausea and vomiting in the 
recovery room in addition to 2 patients in the ward. However, 
there were no significant differences between the two groups. 
Patients in group K did not experience of hallucinations or 
nightmares. There were no significant differences based on the 
time from drug discontinuance until being transferred to the 
recovery room between groups K (11.3 ± 2.7 min) and C (10.8 ± 
2.8 min).
All patients scored 3-4 points according to the Riker 
sedation-agitation scale, thus no one showed signs of sedation. 
VAS scores overall were lower in the K group, and there 
were substantial differences within 3 hours after surgery (Fig. 
1). When the demand for opioids were divided into intervals 
according to time, i.e. 0-1 hour and 1-2 hours after surgery, 
there were significant differences, but not after 2 hours post 
surgery (Fig. 2).
Table 1. Riker Sedation-Agitation Scale
Score Term Descriptor
7
6
5
4
3
2
1
Dangerous agitation
Very agitated
Agitated
Calm and cooperative
Sedated
Very sedated
Unarousable
Pulling at ET tube, trying to remove catheter, climbing over bedrail, striking at staff, thrashing side-to-side
Requiring restraint and frequent verbal reminding of limits, biting ETT
Anxious or physically agitated, calms to verbal instructions
Calm, easily arousable, follows simple commands but drifts off again
Difficult to arouse but awakens to verbal stimuli or gentle shaking, follows simple commands but drifts off again
Arouses to physical stimuli but does not communicate or follow commands, may move spontaneously
Minimal or no response to noxious stimuli, does not communicate or follow commands
Table 2. Patients Characteristics and Intraoperative Data
Group C ( n = 20 ) Group K ( n = 20)
Age (yr)
Weight (kg)
Height (cm)
Time (min)
Total amount remifentanil 
  during anesthesia (µg)
Average of remifentanil 
  concentration (µg/kg/min)
37.6 ± 8.5
57.15 ± 7.7
159.8 ± 6.6
65.4 ± 21.1
574.9 ± 221.0
0.155 ± 0.028
38.8 ± 12.5
57.6 ± 6.9
159.7 ± 6.5
77.3 ± 28.4
620.1 ± 228
0.140 ± 0.023
Values are mean ± SD. There were significant differences between the 
two groups. Time is defined as the time from starting remifentanil 
infusion to wound closure and stopping of the remifentanil infusion. 
Group C (control): infused and injected with 0.9% normal saline. 
Group K  (ketamine): infused with ketamine at 3 µg/kg/min after a 0.3 
mg/kg loading dose of ketamine. 
Table 3. Intraoperative Variables in Each Group
Time point
C group 
(n = 20)
K group 
(n = 20)
MBP (mmHg)
HR (beats/min)
BIS (score)
Baseline
After intubation
Before incision
5 minute after incision 
20 minute after incision
End of surgery
Baseline
After intubation
Before incision
5 minute after incision
20 minute after incision
End of surgery
Baseline
After intubation
Before incision
5 minute after incision
20 minute after incision
End of surgery
83.2 ± 7.2
90.0 ± 14.1
70.4 ± 12.6
84.1 ± 13.8
82.8 ± 10.6
84.7 ± 9.3
79.6 ± 15.2
86.8 ± 14.7
71.0 ± 11.5
69.6 ± 12.9
72.5 ± 12.3
75.2 ± 12.3
91.1 ± 7.5
51.7 ± 9.3
50.3 ± 7.0
50.2 ± 7.9
51.7 ± 6.8
54.6 ± 6.8
85.2 ± 8.0
86.2 ± 18.6
70.1 ± 16.2
88.3 ± 15.8
88.5 ± 11.2
89.2 ± 8.4
73.3 ± 9.7
80.1 ± 17.6
71.2 ± 14.9
66.9 ± 17.3
65.6 ± 11.6
70.7 ± 10.0
93.6 ± 6.1
  60.9 ± 14.0*
 64.2 ± 5.4*
 56.8 ± 6.2*
 57.3 ± 5.9*
57.8 ± 3.5
Values are mean ± SD. There were significant differences in MBP 
& HR between the two groups. BIS was significantly higher in four 
recording time points for K group (*P < 0.05). Group C (control): 
infused and injected with 0.9 % normal saline. Group K (ketamine): 
infused with ketamine at 3 μg/kg/min after a 0.3 mg/kg loading 
dose of ketamine. MBP: mean blood pressure, HR: heart rate, BIS: 
bispectral index.241 www.ekja.org
Korean J Anesthesiol Hong, et al.
Discussion
Throughout this study, we were able to confirm that con-
tinuous infusion of a low dose ketamine decreased early post-
o  pera  tive pain caused by hyperalgesic sensitivity from remi-
fentanil infusion in addition to a decreased use in the total 
amount of opioids used for analgesia. 
Because remifentanil is known for its short acting period, 
it lacks side effects such as delayed consciousness, but rapid 
recovery causes problems such as acute tolerance and hyperal-
gesia resulting in postoperative pain. Postoperative pain 
increases the usage of opioids thus increasing side effects 
caused by these drugs. Therefore, the use of remifentanil during 
anesthesia should be carefully considered for postoperative 
pain.
Several studies state that using remifentanil causes acute 
tolerance or hyperalgesia. Cho et al. [10] showed that when 
anesthetized with sevoflurane during obsteteric surgery, 
combined anesthesia with remifentanil increases early 
postoperative pain. Guignard et al. [2] found that in patients 
receiving colon and rectal surgery, the more reminfentanil 
used increased the demand for opioids for analgesia 24 hours 
after surgery. In a study with volunteers, when 3-4 ng/ml of 
remifentanil infused for 60-100 minutes was discontinued, 
the area of capsaicin-induced hypersensitivity was inhanced 
over 180% [11], and 0.1 μg/kg/min of remifentanil infused 
for 90 minutes expanded the area of electricity-induced skin 
hypersensitivity within 30 minutes [4].
OIH is produced by lowering the threshold below basal 
levels and in order to achieve similar analgesic effects during 
acute tolerance, more opioids are needed. Thus, hyperalgesia 
means an increased sensitivity to pain and tolerance means a 
decreased sensitivity to opioids [12]. Hyperalgesia and acute 
tolerance activates NMDA receptors which creates neuronal 
plasticity and induces central sensitization. Also, descending 
facilitation through opioid sensitive on-cells of the rostral 
ventromedial medulla and direct activation on hyperalgesic 
sensitivity through spinal dynorphin secretion is involved [6]. 
Although the mechanism of remifentanil on NMDA re-
ceptors is still controversial, remifentanil differs from other 
opioids such as fentanyl by acting directly on NMDA receptor 
subunits. Tyrosine phosphorylation of NMDA receptor 2B 
(NR2B), which acts as a key role in signal transduction for 
activating NMDA receptors, plays a role in remifentanil-induced 
hyperalgesia [13]. Remifentanil (Ultiva
Ⓡ, GlaxoSmithKlien, Italy) 
contains glycine as a vehicle. Glycine is inhibitory in the spinal 
cord, but when bound with glutamate on the NMDA receptors, 
it aids in NMDA receptor activation [14].
Joly et al. [15] stated that because acute tolerance and 
hyperalgesia was observed when high doses of remifentanil 
(0.40 μg/kg/min) was infused, establishing a proper dosage of 
remifentanil during surgery is important. Guignard et al. [16] 
also reported that continuous infusion of ketamine decreased 
the dosage of remifentnail infused for maintaining anesthesia 
as well as lowered the overall amount of remifentanil used, 
thus decreasing hyperalgesia. However, in experiments with 
healthy individuals producing hyperalgesia by continuously 
infusing an effect site target concentration 2 ng/ml of remifen-
tanil or at concentrations in our study, early postopera  tive pain 
was increased. The conclusion was that a 3-4 ng/ml effect 
site target concentration of remifentanil is adequate to induce 
hyperalgesia [17]. 
Fig. 1. Postoperative pain up to 7 hours after operation. Data are 
mean ± SD. Group C (control): infused and injected with 0.9 % 
normal saline. Group K (ketamine): infused with ketamine at 3 μg/
kg/min after a 0.3 mg/kg loading dose of ketamine. Each time point 
in group K had a lower VAS score compared to group C (*P < 0.05). 
Fig. 2. Postoperative pain up to 7 hours after operation. Data are 
mean ± SD. Group C(control): infused and injected with 0.9% normal 
saline. Group K (ketamine): infused with ketamine at 3 μg/kg/min 
after a 0.3 mg/kg loading dose of ketamine. Each time point in group 
K had a lower VAS score compared to group C (*P < 0.05). 242 www.ekja.org
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In mastectomy or scoliosis surgery, ketamine administered 
prior to surgery did not have any effects on postoperative pain 
control or the total amount of opioids used [18,19]. However, 
in major operations such as these, noxious stimulation during 
surgery continuously exists and its effects are prolonged 
well after surgery. Therefore, it is almost indisputable that 
prior administration of low dose ketamine is unable to block 
continuous noxious stimuli. Although higher doses of ketamine 
may control pain better than lower doses of ketamine [20], 
side effects such as hallucinations or nightmares appear more 
frequently, thus limiting its value [8]. Our study was restricted to 
those only receiving laparoscopic obstetric surgery in order to 
limit noxious stimuli from tissue damage [21].
Anesthetics may also affect OIH. Shin et al. [22] reported that 
continuous infusion of propofol & remifentanil decreased VAS 
and the use of opioids after surgery was far less when compared 
to the use of sevoflurane and remifentanil. Also, postoperative 
pain and the use of morphine a day after surgery were overall 
decreased when patients were anesthetized with fentanyl & 
propofol as compaired to isoflurane [23]. Propofol suppresses 
NMDA receptor subunits of the glutamate receptor [24], and in 
order to identify the anti-analgesic effects of ketamine which is 
an NMDA receptor antagonist, TIVA with propofol may confuse 
the interpretation of our results and therefore was not used. 
For that reason, sevoflurane was used as the anesthetic in our 
study. Studies investigating remifentanil-induced hyperalgesia 
with sevoflurane as the anesthetic is limited. Kudo et al. [25] 
stated that sevoflurane dose dependently antagonizes NMDA 
receptors, but recent studies report that clinical concentrations 
of sevoflurane are not enough to prevent the antinociceptive 
effects from noxious stimulation or high dose fentanyl-induced 
hyperalgesia [26]. 
Infusion of low dose ketamine and BIS scores may also 
be affected by the anesthetic method. Some studies showed 
that TIVA with propofol and remifentanil do not affect BIS 
when infusing a low dose ketamine [27], while Hans et al. [28] 
reported that anesthesia with sevoflurane increased BIS. In our 
study, BIS was higher in group K than C group, but both were 
within the range of general anesthesia. 
In our study, in order to compare early postoperative pain, 
data were collected within 7 hours post operation. Cho et al. 
[10] reported that patients undergoing obstetric surgery under 
sevoflurane and remifentanil anesthesia, patients infused with 
remifentanil in the first 60 minutes of surgery complained of 
postoperative pain but showed no significant difference in the 
use of postoperative opioids. In our study, patients infused 
with a similar concentration of remifentanil (3.1 ± 1.2 ng/ml) 
complained of hyperalgesia which was most severe 4 hours 
after cessation of remifentanil [11]. Therefore, further pain 
beyond that time period was thought to be due to surgical 
sitmulations [6]. Also, regarding reports on higher infusion of 
opioids worsening OIH [15], our study estimated that infusion 
of a relatively low dose of 0.15 μg/kg/min of remifentanil 
created less postoperative hyperalgesia than studies infusing 
higher doses of remifentanil. 
Currently, ifenprodil, a drug which acts selectively on NMDA 
receptor NR2B subunits, lacks psychomimetic side effects such 
as hallucinations or nightmares compared to the nonselective 
NMDA antagonist ketamine [7,29]. Therefore, applying this drug 
to the OIH field should be considered. Also, local injections 
rather than systemic administration of ketamine may decrease 
complications while controlling pain, which makes further 
clinical studies necessary [30].
The limitation of this study was that only two groups were 
compared, making the determination of the most effective 
dose of remifentanil and ketamine impossible. Thus, further 
studies in other settings are needed. Also, propofol which was 
used during induction of anesthesia can affect OIH, but since 
its use was similarly included in both groups during induction, 
we were able to eliminate its effects. However, in order to study 
antinociceptive hypersensitivity effects of ketamine alone, the 
use of inhalant anesthetics should be taken into consideration 
when choosing the method of induction of anesthesia. 
In conclusion, in patients undergoing laparoscopic obstetric 
surgery using sevoflurane and remifentanil as the anesthetic 
method, early postoperative pain is increased. However, if a low 
dose of ketamine is continuously infused, early postoperative 
pain and the use of postoperative opioids was decreased. Not 
only should hyperalgesia and acute tolerance, which increase 
pain, be considered when using remifentanil, but also efforts to 
prevent these phenomena are warranted.
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